eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 07/04/2011
PIL DIOVAN Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 14/10/2009 and displayed until 07/04/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 30/01/2009 and displayed until 14/10/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 15/08/2008 and displayed until 30/01/2009
Reasons for adding or updating:
  • Change to packaging
  • Change of inactive ingredient
Updated on 04/01/2008 and displayed until 15/08/2008
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 28/09/2007 and displayed until 04/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to side-effects
  • Change to instructions about overdose
Updated on 08/01/2007 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 10/12/2004 and displayed until 08/01/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   valsartan